138 Bremelanotide for Hypoactive Sexual Desire Disorder in the RECONNECT Study: Analysis of Co-Primary Endpoints According to Baseline FSFI Total Scores. (1st April 2019) - Clayton, A.; Kingsberg, S.; DeRogatis, L.; Simon, J.; Jordan, R.; Lucas, J.